GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Menicon Co Ltd (STU:5FR) » Definitions » ROCE %

Menicon Co (STU:5FR) ROCE % : 8.87% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Menicon Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Menicon Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 8.87%.


Menicon Co ROCE % Historical Data

The historical data trend for Menicon Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Menicon Co ROCE % Chart

Menicon Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.57 9.76 9.57 9.62 5.58

Menicon Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.07 6.49 -0.22 8.43 8.87

Menicon Co ROCE % Calculation

Menicon Co's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=47.198/( ( (1065.771 - 170.163) + (1104.182 - 307.363) )/ 2 )
=47.198/( (895.608+796.819)/ 2 )
=47.198/846.2135
=5.58 %

Menicon Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=76.036/( ( (0 - 0) + (1155.492 - 298.264) )/ 1 )
=76.036/( ( 0 + 857.228 )/ 1 )
=76.036/857.228
=8.87 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Menicon Co  (STU:5FR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Menicon Co ROCE % Related Terms

Thank you for viewing the detailed overview of Menicon Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Menicon Co Business Description

Comparable Companies
Traded in Other Exchanges
Address
3-21-19, Aoi, Naka-ku, Aichi, Nagoya, JPN, 460-0006
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.

Menicon Co Headlines

No Headlines